Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: Implication for evaluation of tumor cell depletion after CD34 selection

Bone Marrow Transplantation

Volumn 24, Issue 2, 1999, Pages 229-230

  Tchirkov, A ^a,b   Kanold, J ^a   Combaret, V ^c   Philip, I ^c   Kwiatkowski, F ^d   Malet, P ^b   Demeocq F ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CENTRE LÉON BÉRARD   (France)

^d CENTRE JEAN PERRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; CELL SELECTION; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0032780155     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701865     Document Type: Article

References (4)

1. Leung W, Chen AR, Klann RC et al. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant 1998; 22: 971-979.
2. Combaret V, Favrot MC, Kremens B et al. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer 1989; 59: 844-847.
3. Tchirkov A, Kanold J, Giollant M et al. Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection. Med Ped Oncol 1998; 30: 228-232.
4. D2 immunochemistry. Eur J Cancer 1997; 33: 2024-2030.